More specifically, compared to normal controls, the CCR7, CD19, CXCL13, CXCR4, and SELL genes exhibited significantly elevated expression levels in the RA and UC disease groups, indicating an upregulated state. This evidence concerns the gene CXCR4 and rheumatoid arthritis.